Enamul Hafiz Latifee reports,
China is dropping a requirement that a number of key virus care products get domestic regulatory approval before export, as long as they are approved in the importing countries, the Commerce Ministry of China said on Saturday, 25 April 2020.
China had been stipulating such extra approval at home since the end of March after several European countries complained that Chinese-made test kits were inaccurate, in effect hampering many firms’ efforts to supply global efforts against the coronavirus pandemic.
The new ruling applies to products such as COVID-19 tests, medical masks, protective suits, infrared thermometers, and ventilators.
“Tonight’s new rule is a revision to (the older rule),” said Zhang Shuwen, the CEO of Liming Bio-products, a biotech firm offering coronavirus tests targeting the overseas market. “It’s wrong to have a one-size-fits-all policy…”
“Each country may have different criteria for medicines and medical devices. The priority is to meet the requirement in the countries where the product will be sold, instead of where the product is made,” Zhang said.
The previous ban vexed medical device firms in the cities of Hangzhou and Shenzhen, who tried to seek help from local governments, Zhang added.
Many countries around the world have been scrambling to buy or make enough personal protective equipment for medical staff and care workers at risk of infection, and also tests to trace contagion and identify people who can leave quarantine.